NBOMes-Highly Potent and Toxic Alternatives of LSD
- PMID: 32174803
- PMCID: PMC7054380
- DOI: 10.3389/fnins.2020.00078
NBOMes-Highly Potent and Toxic Alternatives of LSD
Abstract
Recently, a new class of psychedelic compounds named NBOMe (or 25X-NBOMe) has appeared on the illegal drug market. NBOMes are analogs of the 2C family of phenethylamine drugs, originally synthesized by Alexander Shulgin, that contain a N-(2-methoxy)benzyl substituent. The most frequently reported drugs from this group are 25I-NBOMe, 25B-NBOMe, and 25C-NBOMe. NBOMe compounds are ultrapotent and highly efficacious agonists of serotonin 5-HT2A and 5-HT2C receptors (Ki values in low nanomolar range) with more than 1000-fold selectivity for 5-HT2A compared with 5-HT1A. They display higher affinity for 5-HT2A receptors than their 2C counterparts and have markedly lower affinity, potency, and efficacy at the 5-HT2B receptor compared to 5-HT2A or 5-HT2C. The drugs are sold as blotter papers, or in powder, liquid, or tablet form, and they are administered sublingually/buccally, intravenously, via nasal insufflations, or by smoking. Since their introduction in the early 2010s, numerous reports have been published on clinical intoxications and fatalities resulting from the consumption of NBOMe compounds. Commonly observed adverse effects include visual and auditory hallucinations, confusion, anxiety, panic and fear, agitation, uncontrollable violent behavior, seizures, excited delirium, and sympathomimetic signs such mydriasis, tachycardia, hypertension, hyperthermia, and diaphoresis. Rhabdomyolysis, disseminated intravascular coagulation, hypoglycemia, metabolic acidosis, and multiorgan failure were also reported. This survey provides an updated overview of the pharmacological properties, pattern of use, metabolism, and desired effects associated with NBOMe use. Special emphasis is given to cases of non-fatal and lethal intoxication involving these compounds. As the analysis of NBOMes in biological materials can be challenging even for laboratories applying modern sensitive techniques, this paper also presents the analytical methods most commonly used for detection and identification of NBOMes and their metabolites.
Keywords: NBOMe; analytical methods; metabolism; new psychoactive substances; phenethylamines; psychedelics; toxicity.
Copyright © 2020 Zawilska, Kacela and Adamowicz.
Figures
Similar articles
-
2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review.J Anal Toxicol. 2021 Jan 21;44(9):947-956. doi: 10.1093/jat/bkaa022. J Anal Toxicol. 2021. PMID: 32128596
-
Case series: toxicity from 25B-NBOMe--a cluster of N-bomb cases.Clin Toxicol (Phila). 2016;54(2):141-6. doi: 10.3109/15563650.2015.1115056. Epub 2015 Dec 1. Clin Toxicol (Phila). 2016. PMID: 26621342
-
Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.Neuropharmacology. 2018 Nov;142:240-250. doi: 10.1016/j.neuropharm.2018.02.033. Epub 2018 Mar 1. Neuropharmacology. 2018. PMID: 29501528 Free PMC article.
-
Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.Curr Top Behav Neurosci. 2017;32:283-311. doi: 10.1007/7854_2016_64. Curr Top Behav Neurosci. 2017. PMID: 28097528 Review.
-
DARK Classics in Chemical Neuroscience: NBOMes.ACS Chem Neurosci. 2020 Dec 2;11(23):3860-3869. doi: 10.1021/acschemneuro.9b00528. Epub 2019 Nov 12. ACS Chem Neurosci. 2020. PMID: 31657895 Free PMC article. Review.
Cited by
-
Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports.Front Psychiatry. 2021 Apr 23;12:669921. doi: 10.3389/fpsyt.2021.669921. eCollection 2021. Front Psychiatry. 2021. PMID: 33967865 Free PMC article.
-
Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland.Int J Environ Res Public Health. 2022 May 29;19(11):6619. doi: 10.3390/ijerph19116619. Int J Environ Res Public Health. 2022. PMID: 35682204 Free PMC article.
-
Drug-induced Hyperthermic Syndromes in Psychiatry.Clin Psychopharmacol Neurosci. 2021 Feb 28;19(1):1-11. doi: 10.9758/cpn.2021.19.1.1. Clin Psychopharmacol Neurosci. 2021. PMID: 33508784 Free PMC article. Review.
-
Perioperative considerations for patients exposed to hallucinogens.Reg Anesth Pain Med. 2024 Dec 2;49(12):877-882. doi: 10.1136/rapm-2023-104851. Reg Anesth Pain Med. 2024. PMID: 38359966 Free PMC article. Review.
-
Molecular and Medical Aspects of Psychedelics.Int J Mol Sci. 2023 Dec 23;25(1):241. doi: 10.3390/ijms25010241. Int J Mol Sci. 2023. PMID: 38203411 Free PMC article. Review.
References
-
- Abiero A., Botanas C. J., Sayson L. V., Custodio R. J., de la Peña J. B., Kim M., et al. (2019). 5-Methoxy-α-methyltryptamine (5-MeO-AMT), a tryptamine derivative, induces head-twitch responses in mice through the activation of serotonin receptor 2a in the prefrontal cortex. Behav. Brain Res. 359 828–835. 10.1016/j.bbr.2018.07.020 - DOI - PubMed
-
- Al-Iman A., AbdulMajeed B. A. (2017). NBOMe compounds: systematic review and data crunching of the surface web. Glob. J. Health Sci. 9 126–139.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials